Skip to main content
Journal of Medical Toxicology logoLink to Journal of Medical Toxicology
. 2014 Apr 24;10(4):388–391. doi: 10.1007/s13181-014-0400-9

Unintentional Pediatric Ophthalmic Tetrahydrozoline Ingestion: Case Files of the Medical Toxicology Fellowship at the University of California, San Francisco

Suad A Al-Abri 1,, He S Yang 2, Kent R Olson 1
PMCID: PMC4252297  PMID: 24760708

Case Presentation

An 18-month-old child was brought to the emergency department (ED) by his mother for evaluation of diarrhea, vomiting, and somnolence. He was lethargic, with “pinpoint” pupils. Blood pressure was 125/77 mmHg, heart rate was 70/min, temperature was 36.5 °C, respiratory rate was 25/min, and pulse oximetry saturation (SpO2) was 99 % on room air. Blood glucose was 101 mg/dL. Other initial laboratory investigation was unremarkable. Ethanol, acetaminophen, and aspirin were below detection limits. Urine drug screening was negative for amphetamine, methamphetamine, MDMA, barbiturates, benzodiazepines, cocaine, methadone, oxycodone, and opiates. Initial ECG done 3 h after ED arrival showed bradycardia with first-degree heart block. There was no response to 1 mg IV naloxone.

What Is the Differential Diagnosis of His Presenting Clinical Features?

Drowsiness with miotic pupils should always raise the suspicion for opioid intoxication. Response to naloxone may be inadequate or incomplete, such that repeated, increasing doses may be needed [1, 2]. Up to 4 mg of naloxone has been given in some cases involving propoxyphene or codeine [3, 4]. Some sources advise giving 0.1 mg/kg or as much as 10–20 mg if there was no response to the initial dose [3, 5]. Higher doses of naloxone or even continuous infusions have been reported in symptomatic pediatric buprenorphine exposure [6]. Although screening for methadone and oxycodone was included in addition to the opiate urine immunoassay, other synthetic or semisynthetic opioids could have been involved, which might remain undetected. Other drugs that can cause drowsiness and small pupils include benzodiazepines, barbiturates, antipsychotics, other CNS depressants, clonidine, and other imidazoline derivatives [711].

Case Continued

On further questioning, it was discovered the child ingested milk that had been adulterated by tetrahydrozoline eye drops (Visine® Original; Johnson & Johnson Healthcare Products, New Brunswick, NJ) and maliciously intended for another family member. Toxicology lab analysis revealed a tetrahydrozoline concentration in the child’s urine sample of 2,430 ng/mL and a serum tetrahydrozoline level of 21.56 ng/mL. The concentration of tetrahydrozoline in the milk sample was 2,995.4 ng/mL. According to the subsequent investigation, the tetrahydrozoline (approximately 15 mL of 0.05 % solution) was added to a half gallon (1.89 L) of milk, and the child drank an unknown amount of it.

What Are the Common Scenarios for Imidazoline Toxicity?

The most common reported cases of toxicity involve accidental pediatric ingestions of tetrahydrozoline (THZ) 0.05 and 0.1 % solutions [1215]. Other topical imidazolines such as naphazoline and xylometazoline (0.1 % or more) have also been reported to cause toxicity in children [1618]. Some cases involved adulteration of drinks with THZ as a prank, believing it would cause diarrhea [19]. One case involved naphazoline that was mis-prepared at a compounding pharmacy as 4 % instead of 0.05 % [17]. Other case reports have described the use of imidazolines in drug-facilitated sexual assault [20, 21]. Imidazoline derivatives include clonidine, tetrahydrozoline (THZ), tizanidine, naphazoline, and xylometazoline, and ingestion by children can present with similar clinical features of CNS depression and miotic pupils [1113, 16, 18, 22].

What Is the Mechanism of Toxicity of Imidazoline Derivatives?

Most of the imidazolines are designed as decongestants with direct activity on peripheral alpha-1 adrenoreceptors, which explains the transient initial hypertension sometimes seen after oral overdose, as seen in this child initially [23]. Their more conventional antihypertensive effects result from activation of presynaptic alpha-2 adrenoreceptors, which decrease sympathetic output centrally and peripherally, and possibly by increasing vagal activity or activating specific imidazoline receptors in the medulla which cause the hypotension and bradycardia seen later [2327].

What Are the Common Reported Signs and Symptoms of Imidazoline Toxicity?

Altered mental status and bradycardia are the most common reported signs [14]. Respiratory depression, hypotension, miosis, and hypothermia have been reported with variable frequency [14]. Vomiting has been reported as well [18, 28, 29]. Convulsion-like episodes have been reported in two case reports [17, 30]. Transient hypertension is not uncommon [14, 31, 32]. Hypertensive crisis and myocardial infarction were reported in one adult patient with clonidine toxicity [33]. One child had hypoglycemia and hypothermia, which were attributed to poor oral intake and blunted central sympathetic response to cold and hypoglycemia [12].

What Other Drugs can Cause Bradycardia?

Drugs that can cause bradycardia with hypertension include phenylpropanolamine (PPA) [34], phenylephrine [35], and sometimes pseudoephedrine [10]. The mechanism is probably vagally mediated reflex bradycardia due to systemic hypertension. First- and second-degree heart blocks have also been reported [36, 37].

Bradycardia accompanied by hypotension should prompt suspicion of intoxication by beta-adrenergic blockers, calcium channel blockers, and digoxin in addition to the imidazoline derivatives [3840].

What Is the Expected Onset and Duration of Imidazoline Toxicity?

Multiple studies showed that onset of symptoms are rapid and usually within 2 h, and most of the children showed complete resolution of symptoms within 24 h [4143]. Prolonged hypothermia up to 24 h has been reported [44]. Sinoatrial node block lasting up to 20 h has been also reported [20]. A prolonged cardiovascular effect up to 36 h was reported after ingestion of THZ [45].

How Did the Analytical Toxicology Results of the Tetrahydrozoline Concentrations in This Case Compare to Reported Therapeutic and Toxic Levels in the Literature?

Laboratory analysis revealed a urine tetrahydrozoline concentration of 2,430 ng/mL and a serum level of 21.56 ng/mL. The concentration in the adulterated milk sample was 2,995.4 ng/mL. Studies in healthy volunteers after therapeutic instillation of THZ 0.05 % eye drops showed maximum serum concentrations ranging from 0.068 to 0.380 ng/mL and maximum urine concentrations ranged from 44.0 to 400.0 ng/mL [46]. Previous authors reported three cases of pediatric THZ ingestion with plasma concentrations ranging from 23.6 to 41.4 ng/mL and urine concentrations of 9.2 to 49.5 μg/ml (9,200–49,500 ng/mL) [47]. A forensic case report showed that THZ may not be detected in blood after 16–22 h, and checking urine may be better in late presentations [29].

What Is the Recommended Management for Imidazoline Derivative Toxicity?

Treatment of imidazoline derivative toxicity is mainly supportive by assisting ventilation and airway protection for patients with severe central nervous system depression [12] and support of blood pressure and heart rate when needed. Close observation of neurological and hemodynamic status of the patients for at least 24 h and supporting their hemodynamics are done if needed with intravascular fluid in cases of hypotension and atropine if significant bradycardia and hypotension occur [16]. If the initial transient hypertension is severe, it should be treated with a short-acting vasodilator like nitroprusside or phentolamine [32, 48].

What Is the Role of Naloxone in Treatment of Imidazoline Toxicity?

There are some case reports suggesting response after naloxone administration in THZ and clonidine overdose, although concomitant opioid exposure was not adequately excluded by toxicological testing [11, 4951]. The purported mechanism of naloxone effect was reversal of clonidine-enhanced endogenous opiate release, but animal studies have not confirmed this [52, 53]. There are several reports of failure of naloxone to reverse clonidine [54, 55] and toxicity from THZ and other imidazoline derivatives [12, 16, 44]. Of course, it is reasonable to try naloxone in a patient presenting with neurological and respiratory depression and miotic pupils, because of the possibility of unrecognized opioid toxicity [56]. Although worsened hypertension has been reported in a case series after naloxone treatment for pediatric clonidine poisoning, hypertension in these cases occurred following multiple treatments including atropine, making the causative role of naloxone unclear [57].

Case Conclusion

The child was admitted for observation. After 20 h, he had a heart rate of 90/min and a blood pressure of 90/50 mmHg. His mental status was back to baseline. No treatment was given. Child protective services and the police department were involved in the investigation of the circumstances surrounding the child’s exposure.

Acknowledgments

Conflict of Interest

None of the authors have any conflicts of interest.

Funding Source

No funding.

References

  • 1.Sachdeva DK, Stadnyk JM. Are one or two dangerous? Opioid exposure in toddlers. J Emerg Med. 2005;1:77–84. doi: 10.1016/j.jemermed.2004.12.015. [DOI] [PubMed] [Google Scholar]
  • 2.Gourlay GK, Coulthard K. The role of naloxone infusions in the treatment of overdoses of long half-life narcotic agonists: application to nor-methadone. Br J Clin Pharmacol. 1983;15(2):269–271. doi: 10.1111/j.1365-2125.1983.tb01498.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Moore RA, Rumack BH, Conner CS, Peterson RG. Naloxone: underdosage after narcotic poisoning. Am J Dis Child. 1980;134(2):156–158. doi: 10.1001/archpedi.1980.02130140030009. [DOI] [PubMed] [Google Scholar]
  • 4.Lewis JM, Klein-Schwartz W, Benson BE, Oderda GM, Takai S. Continuous naloxone infusion in pediatric narcotic overdose. Am J Dis Child. 1984;138(10):944–946. doi: 10.1001/archpedi.1984.02140480046014. [DOI] [PubMed] [Google Scholar]
  • 5.Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS. Goldfrank’s toxicologic emergencies. 5. East Norwalk: Appleton and Lange; 1994. p. 784. [Google Scholar]
  • 6.Pedapati EV, Bateman ST. Toddlers requiring pediatric intensive care unit admission following at-home exposure to buprenorphine/naloxone. Pediatr Crit Care Med. 2011;12(2):e102–e107. doi: 10.1097/PCC.0b013e3181f3a118. [DOI] [PubMed] [Google Scholar]
  • 7.Welch TR, Rumack BH, Hammond K. Clonazepam overdose resulting in cyclic coma. Clin Toxicol. 1977;10(4):433–436. doi: 10.3109/15563657709046280. [DOI] [PubMed] [Google Scholar]
  • 8.Mitchell AA, Lovejoy FH, Goldman P. Drug ingestions associated with miosis in comatose children. J Pediatr. 1976;89(2):303–305. doi: 10.1016/S0022-3476(76)80474-X. [DOI] [PubMed] [Google Scholar]
  • 9.Isbister GK, Balit CR, Kilham HA. Antipsychotic poisoning in young children: a systematic review. Drug Saf. 2005;28(11):1029–1044. doi: 10.2165/00002018-200528110-00004. [DOI] [PubMed] [Google Scholar]
  • 10.Gunn VL, Taha SH, Liebelt EL, Serwint JR. Toxicity of over-the-counter cough and cold medications. Pediatrics. 2001;108(3):E52. doi: 10.1542/peds.108.3.e52. [DOI] [PubMed] [Google Scholar]
  • 11.Bamshad MJ, Wasserman GS. Pediatric clonidine intoxications. Vet Hum Toxicol. 1990;32(3):220–223. [PubMed] [Google Scholar]
  • 12.Tobias JD. Central nervous system depression following accidental ingestion of Visine eye drops. Clin Pediatr (Phila) 1996;35(10):539–540. doi: 10.1177/000992289603501010. [DOI] [PubMed] [Google Scholar]
  • 13.Jensen P, Edgren B, Hall L, Ring JC. Hemodynamic effects following ingestion of an imidazoline-containing product. Pediatr Emerg Care. 1989;5(2):110–112. doi: 10.1097/00006565-198906000-00011. [DOI] [PubMed] [Google Scholar]
  • 14.Eddy O, Howell JM. Are one or two dangerous? Clonidine and topical imidazolines exposure in toddlers. J Emerg Med. 2003;25(3):297–302. doi: 10.1016/S0736-4679(03)00206-3. [DOI] [PubMed] [Google Scholar]
  • 15.Daggy A, Kaplan R, Roberge R, Akhtar J. Pediatric Visine (tetrahydrozoline) ingestion: case report and review of imidazoline toxicity. Vet Hum Toxicol. 2003;45(4):210–212. [PubMed] [Google Scholar]
  • 16.Mahieu LM, Rooman RP, Goossens E. Imidazoline intoxication in children. Eur J Pediatr. 1993;152(11):944–946. doi: 10.1007/BF01957538. [DOI] [PubMed] [Google Scholar]
  • 17.Musshoff F, Gerschlauer A, Madea B. Naphazoline intoxication in a child—a clinical and forensic toxicological case. Forensic Sci Int. 2003;134(2–3):234–237. doi: 10.1016/S0379-0738(03)00158-0. [DOI] [PubMed] [Google Scholar]
  • 18.Van Riel AJ, Hunault C, van Riemsdijk TE, de Vries I, Meulenbelt J. A case series of xylometazoline overdose in children. Clin Toxicol (Phila) 2007;45(3):290–294. doi: 10.1080/15563650601033326. [DOI] [PubMed] [Google Scholar]
  • 19.Osterhoudt KC, Henretig FM. Sinoatrial node arrest following tetrahydrozoline ingestion. J Emerg Med. 2004;27(3):313–314. doi: 10.1016/j.jemermed.2004.06.007. [DOI] [PubMed] [Google Scholar]
  • 20.Stillwell ME, Saady JJ. Use of tetrahydrozoline for chemical submission. Forensic Sci Int. 2012;221(1–3):e12–e16. doi: 10.1016/j.forsciint.2012.04.004. [DOI] [PubMed] [Google Scholar]
  • 21.Spiller HA, Rogers J, Sawyer TS. Drug facilitated sexual assault using an over-the-counter ocular solution containing tetrahydrozoline (Visine) Leg Med (Tokyo) 2007;9(4):192–195. doi: 10.1016/j.legalmed.2007.01.005. [DOI] [PubMed] [Google Scholar]
  • 22.Spiller HA, Bosse GM, Adamson LA. Retrospective review of Tizanidine (Zanaflex) overdose. J Toxicol Clin Toxicol. 2004;42(5):593–596. doi: 10.1081/CLT-200026978. [DOI] [PubMed] [Google Scholar]
  • 23.Van Zwieten PA. Pharmacology of centrally acting hypotensive drugs. Br J Clin Pharmacol. 1980;10(Suppl 1):13S–20S. doi: 10.1111/j.1365-2125.1980.tb04899.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Pichler L, Kobinger W. Proceedings: central nervous cardiovascular depression, a potential action of alpha-adrenoceptors stimulating imidazoline derivatives. Naunyn Schmiedeberg’s Arch Pharmacol. 1975;287(Suppl):R20. [PubMed] [Google Scholar]
  • 25.De Jonge A, Slothorst-Grisdijk FP, Timmermans PB, Van Zwieten PA. Discrimination between peripheral and central alpha-adrenergic effects using meta-substituted imidazolidines. Eur J Pharmacol. 1981;71(4):411–420. doi: 10.1016/0014-2999(81)90185-0. [DOI] [PubMed] [Google Scholar]
  • 26.Head GA, Chan CK, Burke SL. Relationship between imidazoline and alpha2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents. J Auton Nerv Syst. 1998;72(2–3):163–169. doi: 10.1016/S0165-1838(98)00101-5. [DOI] [PubMed] [Google Scholar]
  • 27.Szabo B, Bock C, Nordheim U, Niederhoffer N. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine. Ann N Y Acad Sci. 1999;881:253–264. doi: 10.1111/j.1749-6632.1999.tb09367.x. [DOI] [PubMed] [Google Scholar]
  • 28.Klein-Schwartz W, Gorman R, Oderda GM, Baig A. Central nervous system depression from ingestion of nonprescription eyedrops. Am J Emerg Med. 1984;2(3):217–218. doi: 10.1016/0735-6757(84)90007-X. [DOI] [PubMed] [Google Scholar]
  • 29.Spiller HA, Siewert DJ. Drug-facilitated sexual assault using tetrahydrozoline. J Forensic Sci. 2012;57(3):835–838. doi: 10.1111/j.1556-4029.2011.02026.x. [DOI] [PubMed] [Google Scholar]
  • 30.Söderman P, Sahlberg D, Wiholm BE. CNS reactions to nose drops in small children. Lancet. 1984;1(8376):573. doi: 10.1016/S0140-6736(84)90978-4. [DOI] [PubMed] [Google Scholar]
  • 31.Seger DL. Clonidine toxicity revisited. J Toxicol Clin Toxicol. 2002;40(2):145–155. doi: 10.1081/CLT-120004402. [DOI] [PubMed] [Google Scholar]
  • 32.Dire DJ, Kuhns DW. The use of sublingual nifedipine in a patient with a clonidine overdose. J Emerg Med. 1988;6(2):125–128. doi: 10.1016/0736-4679(88)90152-7. [DOI] [PubMed] [Google Scholar]
  • 33.Frye CB, Vance MA. Hypertensive crisis and myocardial infarction following massive clonidine overdose. Ann Pharmacother. 2000;34(5):611–615. doi: 10.1345/aph.19257. [DOI] [PubMed] [Google Scholar]
  • 34.Delorio NM. Cerebral infarcts in a pediatric patient secondary to phenylpropanolamine, a recalled medication. J Emerg Med. 2004;26(3):305–307. doi: 10.1016/j.jemermed.2003.09.009. [DOI] [PubMed] [Google Scholar]
  • 35.Vaughan RW. Ventricular arrhythmias after topical vasoconstrictors. Anesth Analg. 1973;52(2):161–165. doi: 10.1213/00000539-197303000-00003. [DOI] [PubMed] [Google Scholar]
  • 36.Williams PL, Krafcik JM, Potter BB, Hooper JH, Hearne MJ. Cardiac toxicity of clonidine. Chest. 1977;72(6):784–785. doi: 10.1378/chest.72.6.784. [DOI] [PubMed] [Google Scholar]
  • 37.Ciaccheri M, Dolara A, Manetti A, Botti P, Zorn M, Peruzzi S. A-V block by an overdose of Clonidine. Acta Cardiol. 1983;38(3):233–236. [PubMed] [Google Scholar]
  • 38.Truitt CA, Brooks DE, Dommer P, LoVecchio F. Outcomes of unintentional beta-blocker or calcium channel blocker overdoses: a retrospective review of poison center data. J Med Toxicol. 2012;8(2):135–139. doi: 10.1007/s13181-011-0209-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Ranniger C, Roche C. Are one or two dangerous? Calcium channel blocker exposure in toddlers. J Emerg Med. 2007;33(2):145–154. doi: 10.1016/j.jemermed.2007.02.010. [DOI] [PubMed] [Google Scholar]
  • 40.Thacker D, Sharma J. Digoxin toxicity. Clin Pediatr (Phila) 2007;46(3):276–279. doi: 10.1177/0009922806294805. [DOI] [PubMed] [Google Scholar]
  • 41.Bucaretchi F, Dragosavac S, Vieira RJ. Acute exposure to imidazoline derivatives in children. J Pediatr (Rio J) 2003;79(6):519–524. doi: 10.2223/JPED.1112. [DOI] [PubMed] [Google Scholar]
  • 42.Higgins GL, 3rd, Campbell B, Wallace K, Talbot S. Pediatric poisoning from over-the-counter imidazoline-containing products. Ann Emerg Med. 1991;20(6):655–658. doi: 10.1016/S0196-0644(05)82388-1. [DOI] [PubMed] [Google Scholar]
  • 43.Spiller HA, Klein-Schwartz W, Colvin JM, Villalobos D, Johnson PB, Anderson DL. Toxic clonidine ingestion in children. J Pediatr. 2005;146(2):263–266. doi: 10.1016/j.jpeds.2004.09.027. [DOI] [PubMed] [Google Scholar]
  • 44.Paksu MS, Paksu S, Akkuş T, Baysal K. One drop can be beneficial, one swig can be deadly: tetrahydrozoline intoxication. Turk J Pediatr. 2012;54(6):658–660. [PubMed] [Google Scholar]
  • 45.Spiller H, Griffith J. Prolonged cardiovascular effects after unintentional ingestion of tetrahydrozoline. Clin Toxicol (Phila) 2008;46(2):171–172. doi: 10.1080/15563650701258070. [DOI] [PubMed] [Google Scholar]
  • 46.Carr ME, Engebretsen KM, Ho B, Anderson CP. Tetrahydrozoline (Visine®) concentrations in serum and urine during therapeutic ocular dosing: a necessary first step in determining an overdose. Clin Toxicol (Phila) 2011;49(9):810–814. doi: 10.3109/15563650.2011.615064. [DOI] [PubMed] [Google Scholar]
  • 47.Lowry JA, Garg U. Serum concentrations in three children with unintentional tetrahydrozoline overdose. Clin Toxicol (Phila) 2011;49(5):434–435. doi: 10.3109/15563650.2011.586639. [DOI] [PubMed] [Google Scholar]
  • 48.Marruecos L, Roglan A, Frati ME, Artigas A. Clonidine overdose. Crit Care Med. 1983;11(12):959–960. doi: 10.1097/00003246-198312000-00014. [DOI] [PubMed] [Google Scholar]
  • 49.Homes JF, Berman DA. Use of naloxone to reverse symptomatic tetrahydrozoline overdose in a child. Pediatr Emerg Care. 1999;15(3):193–194. doi: 10.1097/00006565-199906000-00008. [DOI] [PubMed] [Google Scholar]
  • 50.Katar S, Taskesen M, Okur N. Naloxone use in a newborn with apnea due to tetrahydrozoline intoxication. Pediatr Int. 2010;52(3):488–489. doi: 10.1111/j.1442-200X.2010.03040.x. [DOI] [PubMed] [Google Scholar]
  • 51.Kulig K, Duffy J, Rumack BH, Mauro R, Gaylord M. Naloxone for treatment of clonidine overdose. JAMA. 1982;247(12):1697. doi: 10.1001/jama.1982.03320370015013. [DOI] [PubMed] [Google Scholar]
  • 52.Srivastava RK, Kaur AH. Failure of reversal of cardiovascular responses of clonidine by centrally administered naloxone in anaesthetised rats. Indian J Exp Biol. 1989;27(7):628–630. [PubMed] [Google Scholar]
  • 53.Shropshire AT, Wendt RL. Failure of naloxone to reduce clonidine-induced changes in blood pressure, heart rate and sympathetic nerve firing in cats. J Pharmacol Exp Ther. 1983;224(3):494–500. [PubMed] [Google Scholar]
  • 54.Banner W, Jr, Lund ME, Clawson L. Failure of naloxone to reverse clonidine toxic effect. Am J Dis Child. 1983;137(12):1170–1171. doi: 10.1001/archpedi.1983.02140380030009. [DOI] [PubMed] [Google Scholar]
  • 55.Ahmad SA, Scolnik D, Snehal V, Glatstein M. Use of naloxone for clonidine intoxication in the pediatric age group: case report and review of the literature. Am J Ther. 2013 doi: 10.1097/MJT.0b013e318293b0e8. [DOI] [PubMed] [Google Scholar]
  • 56.Osterhoudt KC, Calello DP. Obtundation in a toddler: naloxone is fundamental. Am J Emerg Med. 2007;25(4):481. doi: 10.1016/j.ajem.2005.09.011. [DOI] [PubMed] [Google Scholar]
  • 57.Gremse DA, Artman M, Boerth RC. Hypertension associated with naloxone treatment for clonidine poisoning. J Pediatr. 1986;108(5 Pt 1):776–778. doi: 10.1016/S0022-3476(86)81067-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Toxicology are provided here courtesy of Springer

RESOURCES